Announcements Trials

Browse Landscape

Status

Recruiting 1 Completed 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Neoplasms 38 Breast Neoplasms 31 Lung Neoplasms 25 Colorectal Neoplasms 15 Prostatic Neoplasms 13 Pancreatic Neoplasms 11 Ovarian Neoplasms 11 Carcinoma, Non-Small-Cell Lung 10 Head and Neck Neoplasms 9 Sarcoma 8 Colonic Neoplasms 8 Carcinoma, Hepatocellular 8 Uterine Cervical Neoplasms 7 Glioma 7 Esophageal Neoplasms 7 Melanoma 6 Lymphoma 6 Endometrial Neoplasms 6 Neoplastic Cells, Circulating 5 Multiple Myeloma 5 Brain Neoplasms 5 Stomach Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Neoplasm, Residual 4 Gastrointestinal Neoplasms 4 Carcinoma, Squamous Cell 4 Carcinoma, Renal Cell 4 Adenocarcinoma 4 Thrombosis 3 Rectal Neoplasms 3

Interventions

lutetium Lu 177 dotatate 10 Everolimus 5 lanreotide 4 gallium Ga 68 dotatate 4 Nivolumab 4 Magnetic Resonance Spectroscopy 4 177Lu-octreotide, DOTA(0)-Tyr(3)- 4 olaparib 3 Temozolomide 3 Somatostatin 3 Capecitabine 3 surufatinib 2 pembrolizumab 2 copper dotatate CU-64 2 cabozantinib 2 amino-acid, glucose, and electrolyte solution 2 Specimen Handling 2 Octreotide 2 Lutetium-177 2 Lutetium 2 Injections 2 Fluorodeoxyglucose F18 2 Cyclophosphamide 2 tivozanib 1 talazoparib 1 sintilimab 1 repotrectinib 1 lenvatinib 1 guarana powder 1 gadoteridol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Neuroendocrine Tumors × Blood Specimen Collection × Clear all

NCT06430021 2026-05-22

PRO-NEM1

Centre Hospitalier Universitaire Dijon

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡